Literature DB >> 2866785

The tremorolytic action of beta-adrenoceptor blockers in essential, physiological and isoprenaline-induced tremor is mediated by beta-adrenoceptors located in a deep peripheral compartment.

B Abila, J F Wilson, R W Marshall, A Richens.   

Abstract

The effects of intravenous propranolol 100 micrograms kg-1, sotalol 500 micrograms kg-1, timolol 7.8 micrograms kg-1, atenolol 125 micrograms kg-1 and placebo on essential, physiological and isoprenaline-induced tremor were studied. These beta-adrenoceptor blocker doses produced equal reduction of standing-induced tachycardia in essential tremor patients. Atenolol produced significantly less reduction of essential and isoprenaline-induced tremor than the non-selective drugs, confirming the importance of beta 2-adrenoceptor blockade in these effects. Propranolol and sotalol produced equal maximal inhibition of isoprenaline-induced tremor but propranolol was significantly more effective in reducing essential tremor. The rate of development of the tremorolytic effect was similar in essential, physiological and isoprenaline-induced tremors but all tremor responses developed significantly more slowly than the heart rate responses. It is proposed that these results indicate that the tremorolytic activity of beta-adrenoceptor blockers in essential, physiological and isoprenaline-induced tremor is exerted via the same beta 2-adrenoceptors located in a deep peripheral compartment which is thought to be in the muscle spindles.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2866785      PMCID: PMC1400891          DOI: 10.1111/j.1365-2125.1985.tb05079.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Morphometric comparison of capillaries in muscle spindles, nerve, and muscle.

Authors:  T Miyoshi; W R Kennedy; K S Yoon
Journal:  Arch Neurol       Date:  1979-09

2.  Beta-adrenoreceptor mechanisms in essential tremor: a comparative single dose study of the effect of a non-selective and a beta-2 selective adrenoreceptor antagonist.

Authors:  L Cleeves; L J Findley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-09       Impact factor: 10.154

3.  Beta-adrenoceptor blockers and the blood-brian barrier.

Authors:  G Neil-Dwyer; J Bartlett; J McAinsh; J M Cruickshank
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

4.  beta-Adrenoceptor antagonists and essential tremor.

Authors:  P N Leigh; C D Marsden; A Twomey; D Jefferson
Journal:  Lancet       Date:  1981-05-16       Impact factor: 79.321

5.  beta-Adrenoreceptor antagonists in essential tremor.

Authors:  D Jefferson; P Jenner; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-10       Impact factor: 10.154

6.  Treatment of essential tremor with metoprolol.

Authors:  O Ljung
Journal:  N Engl J Med       Date:  1979-11-01       Impact factor: 91.245

7.  Peripheral beta-adrenergic receptors concerned with tremor.

Authors:  C D Marsden; T H Foley; D A Owen; R G McAllister
Journal:  Clin Sci       Date:  1967-08       Impact factor: 6.124

8.  Effects of the beta-adrenoceptor blocking agent sotalol on CNS: sleep, EEG, and psychophysiological parameters.

Authors:  W Bender; W Greil; E Rüther; K Schnelle
Journal:  J Clin Pharmacol       Date:  1979 Aug-Sep       Impact factor: 3.126

9.  Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects.

Authors:  E Perucca; H Pickles; A Richens
Journal:  Clin Pharmacol Ther       Date:  1981-04       Impact factor: 6.875

10.  Tremor caused by sympathomimetics is mediated by beta2-adrenoreceptors.

Authors:  S Larsson; N Svedmyr
Journal:  Scand J Respir Dis       Date:  1977
View more
  16 in total

1.  The comparative effects of ICI 118551 and propranolol on essential tremor.

Authors:  D Jefferson; H J Wharrad; A T Birmingham; J M Patrick
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

2.  Update on treatment of essential tremor.

Authors:  Theresa A Zesiewicz; Jessica D Shaw; Kevin G Allison; Joseph S Staffetti; Michael S Okun; Kelly L Sullivan
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598

Review 3.  Pharmacological management of essential tremor.

Authors:  Reza Sadeghi; William G Ondo
Journal:  Drugs       Date:  2010-12-03       Impact factor: 9.546

Review 4.  Emerging strategies in the management of essential tremor.

Authors:  Peter Hedera
Journal:  Ther Adv Neurol Disord       Date:  2016-11-30       Impact factor: 6.570

5.  Effects of high ambient temperature on parasympathetically mediated cardiovascular reflexes in normal man.

Authors:  W M Banjar; J Gazzaz; R W Langley; C M Bradshaw; E Szabadi
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

Review 6.  Linking Essential Tremor to the Cerebellum: Neurochemical Evidence.

Authors:  Juan Marin-Lahoz; Alexandre Gironell
Journal:  Cerebellum       Date:  2016-06       Impact factor: 3.847

Review 7.  Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association.

Authors:  Mario Zappia; Alberto Albanese; Elisa Bruno; Carlo Colosimo; Graziella Filippini; Paolo Martinelli; Alessandra Nicoletti; Graziella Quattrocchi; Giovanni Abbruzzese; Alfredo Berardelli; Roberta Allegra; Maria Stella Aniello; Antonio E Elia; Davide Martino; Daniela Murgia; Marina Picillo; Giovanna Squintani
Journal:  J Neurol       Date:  2012-08-11       Impact factor: 4.849

8.  Is postural tremor size controlled by interstitial potassium concentration in muscle?

Authors:  M D Lakie; N R Hayes; N Combes; N Langford
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

9.  An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.

Authors:  P M McCaffrey; J G Riddell; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

Review 10.  Epidemiology and management of essential tremor in children.

Authors:  Joseph Ferrara; Joseph Jankovic
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.